NCT01528774View on ClinicalTrials.gov

Culture and Characterization of Circulating Tumor Cells (CTC) in Melanoma and Other Cancers

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Melanoma
Interventions
OTHER

Blood Draw

Approximately 40 cc of blood will be drawn from participants at a time when they are having blood drawn for routine or treatment-related purposes. Sequential samples may be obtained in the same manner from selected patients to allow exploration of potential correlation of CTC with response to treatment, progression-free survival and overall survival.

Trial Locations (1)

89148

Comprehensive Cancer Centers of Nevada, Las Vegas

All Listed Sponsors
collaborator

TrueCells, LLC

INDUSTRY

collaborator

Comprehensive Cancer Centers of Nevada

OTHER

collaborator

University of Pittsburgh

OTHER

lead

Wolfram Samlowski

OTHER

NCT01528774 - Culture and Characterization of Circulating Tumor Cells (CTC) in Melanoma and Other Cancers | Biotech Hunter | Biotech Hunter